CHARACTERISTICS OF SLOW-RESPONDERS TO LONG-TERM NAIVE-ENTECAVIR THERAPY IN CHRONIC HEPATITIS B JAPANESE PATIENTS

被引：0

作者：

Orito, Etsuro ^{[1
]}

Fujiwara, Kei ^{[1
]}

Kanie, Hiroshi ^{[1
]}

Ban, Tesshin ^{[1
]}

Yamada, Tomonori ^{[1
]}

Hayashi, Katsumi ^{[1
]}

机构：

[1] Nagoya Daini Red Cross Hosp, Nagoya, Aichi, Japan

来源：

HEPATOLOGY | 2011年 / 54卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

页码：1025A / 1025A

页数：1

共 50 条

[31] Evaluation of long-term entecavir treatment in stable chronic hepatitis B patients switched from lamivudine therapy
Tatsuya Ide
Michio Sata
Kazuaki Chayama
Michiko Shindo
Joji Toyota
Satoshi Mochida
Eiichi Tomita
Hiromitsu Kumada
Gotaro Yamada
Hiroshi Yatsuhashi
Norio Hayashi
Hiroki Ishikawa
Taku Seriu
Masao Omata
Hepatology International, 2010, 4 : 594 - 600
[32] ENTECAVIR RESISTANCE IN ENTECAVIR NAIVE LAMIVUDINE TREATED CHRONIC HEPATITIS B PATIENTS
Sayan, Murat
Hulagu, Sadettin
Akhan, Sila Cetin
Senturk, Omer
Meric, Meliha
Cekmen, Mustafa
MIKROBIYOLOJI BULTENI, 2009, 43 (03): : 425 - 432
[33] Long term efficacy, safety and resistance analyses of entecavir (ETV) treatment in Japanese nucleoside-naive patients with chronic hepatitis B (CHB)
Mochida, S.
Takaguchi, K.
Yokosuka, O.
Fujioka, S.
Hayashi, N.
Shindo, M.
Chayama, K.
Toyota, J.
Ishikawa, H.
Seriu, T.
Omata, O.
JOURNAL OF HEPATOLOGY, 2008, 48 : S262 - S262
[34] Similar risk of hepatocellular carcinoma during long-term entecavir or tenofovir therapy in Caucasian patients with chronic hepatitis B
Wen, Zhili
Feng, Yuliang
Yan, Xiaohua
JOURNAL OF HEPATOLOGY, 2021, 74 (01) : 245 - 246
[35] Similar risk of hepatocellular carcinoma during long-term entecavir or tenofovir therapy in Caucasian patients with chronic hepatitis B
Papatheodoridis, George, V
Dalekos, George N.
Idilman, Ramazan
Sypsa, Vana
Van Boemmel, Florian
Buti, Maria
Calleja, Jose Luis
Goulis, John
Manolakopoulos, Spilios
Loglio, Alessandro
Papatheodoridi, Margarita
Gatselis, Nikolaos
Veelken, Rhea
Lopez-Gomez, Marta
Hansen, Bettina E.
Savvidou, Savvoula
Kourikou, Anastasia
Vlachogiannakos, John
Galanis, Kostas
Yurdaydin, Cihan
Esteban, Rafael
Janssen, Harry L. A.
Berg, Thomas
Lampertico, Pietro
JOURNAL OF HEPATOLOGY, 2020, 73 (05) : 1037 - 1045
[36] Real-world efficacy of long-term entecavir and tenofovir in patients with chronic hepatitis B
Le, S.
Ratnam, D.
Van Leest, R.
Kemp, W.
Roberts, S.
Nicoll, A.
Gow, P.
Bell, S.
Sood, S.
Arachchi, N.
Lubel, J.
Ryan, M.
Howell, J.
Majeed, A.
Dev, A.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2019, 34 : 95 - 95
[37] Long-Term Entecavir Therapy Results in the Reversal of Fibrosis/Cirrhosis and Continued Histological Improvement in Patients with Chronic Hepatitis B
Chang, Ting-Tsung
Liaw, Yun-Fan
Wu, Shun-Sheng
Schiff, Eugene
Han, Kwang-Hyub
Lai, Ching-Lung
Safadi, Rifaat
Lee, Samuel S.
Halota, Waldemar
Goodman, Zachary
Chi, Yun-Chan
Zhang, Hui
Hindes, Robert
Iloeje, Uchenna
Beebe, Suzanne
Kreter, Bruce
HEPATOLOGY, 2010, 52 (03) : 886 - 893
[38] The correlation between HBeAg levels and entecavir long-term efficacy in chronic hepatitis B patients
俎燕会
China Medical Abstracts(Internal Medicine), 2012, 29 (04) : 225 - 225
[39] Long-term virological outcome in chronic hepatitis B patients with a partial virological response to entecavir
Jo, Yu Jung
Kim, Kyung-Ah
Lee, June Sung
Kim, Nam-Hoon
Bae, Won Ki
Song, Tae June
Kim, Jeong Wook
KOREAN JOURNAL OF INTERNAL MEDICINE, 2015, 30 (02): : 170 - 176
[40] Long-term effects of entecavir and tenofovir treatment on the fibrotic burden in patients with chronic hepatitis B
Chon, Young Eun
Kim, Seung Up
Seo, Yeon Seok
Lee, Hye Won
Lee, Han Ah
Kim, Mi Na
Roh, Yun Ho
Park, Jun Yong
Kim, Do Young
Ahn, Sang Hoon
Tak, Won Young
Park, Soo Young
Kim, Beom Kyung
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2022, 37 (01) : 200 - 207

← 1 2 3 4 5 →